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INTRODUCTION:  Eccrine  porocarcinoma  (EPC)  is a slow-growing  carcinoma  arising  from  the  eccrine  sweat
glands. Based  on its clinical  presentation  it can  be  confused  with  malignant  and benign  skin  lesions,
both.  Histological  examination  is  essential  to formulate  a correct  diagnosis.  Surgical  excision  with  clear
margins  is  the  standard  therapeutic  approach  while  the  role  of  sentinel  lymph  node  biopsy  (SNLB)  remains
controversial.
CASE  PRESENTATION:  The  Authors  report  two  cases  of  EPC  of  the  lower  limbs  occurred  in two  women.
Patients  were  treated  by wide  surgical  excision  of  the  lesion  and  SNLB.  6 months  follow-up  was  disease
free  for  both  patients.ccrine carcinomas CONCLUSION:  Although  a rare cutaneous  tumor,  EPC has  to be  taken  into  account  in the  differential
diagnosis  of  malignant  skin  lesions  because  of  its  possible  loco-regional  aggressiveness  and  related  mor-
bidity. Among  the  available  treatment  options,  surgical  excision  is  considered  the standard  approach
whereas  the  role  of  SNLB  is controversial  although  the  Authors  discuss  a  possible  usefulness  for  staging
and  diagnosis.
©  2018  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
 articaccess
. Introduction
Eccrine porocarcinoma (EPC), ﬁrst described by Pinkus and
ehregan in 1963 [1], is a rare form of skin cancer. Its presenta-
ions very often mimics a cutaneous lesion similar to other forms
f benign and malignant cutaneous neoplasms [1,2]. Accurate diag-
osis, optimal treatment and prognosis of EPC are still challenging
ue to scant literature reports. Eccrine carcinomas may  have an
levate presence of regional lymph node metastasis, thus some
uthors have advocated SLNB for all or some patients, but its utility
or staging purposes remains unknown.
We  report two cases of EPC in which the sentinel lymph node
iopsy (SLNB) was performed [17].∗ Corresponding author.
E-mail address: sergio.bertoglio@unige.it (S. Bertoglio).
ttps://doi.org/10.1016/j.ijscr.2018.10.047
210-2612/© 2018 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group
rg/licenses/by/4.0/).le under  the  CC  BY license  (http://creativecommons.org/licenses/by/4.0/).
2. Case presentation
2.1. Case 1
During August 2017, a 64 years woman was  seen at our depart-
ment after a previous cutaneous lesion excision with an histological
diagnosis of porocarcinoma of the left thigh. The histological
examination revealed a poroid neoplasm extending into the deep
dermis to the level of the dermal-subcutaneous junction with
a thickness of 5.4 mm,  10–12 mitoses per 10 high-power ﬁeld,
absence of lymphovascular invasion and free margins with a clear-
ing distance of 1.5 mm.  Hematoxilyn-eosin staining (Fig. 1) and
Immunohistochemical (IHC) analysis showed positive staining for
carcinoembryonic antigen (CEA), cytokeratin (CK) 5,7 and epithelial
membrane antigen (EMA).
She had a past medical history of appendicitis in childhood,
anxious-depressive syndrome, osteoporosis, hiatal hernia, obesity
and smoked about 20 cigarettes a day. New York Heart Associa-
tion (NYHA) score was 1 and American Society of Anesthesiologists
(ASA) score was  1. The patient had no anorexia and weight loss
and the examination did not reveal any inguinal lymphadenopathy.
Laboratory tests, including blood count, biochemical investigations
and serological viral markers were normal. The electrocardiogram
 Ltd. This is an open access article under the CC BY license (http://creativecommons.
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howed sinus rhythm and the chest radiograph showed no signs
f pleural or parenchymal lesions. After multidisciplinary discus-
ion and based on the sub-optimal clearing margin we performed
 re-excision of the previous wound to ensure wider safety mar-
ins of at least 20 mm similarly to surgical strategy for other skin
umors and in particular melanoma. At that time it was also decided
o perform a SLNB; preoperative lymph-node scintigraphy showed
he presence of two sentinel lymph nodes in the left groin that
ere excised during SLNB. Recovery from surgery was unevent-
ul and the patient was discharged on the ﬁrst post-operative day.
istopathological examination found no signs of residual or satel-
ite neoplasia in the surgical sample and the two  retrieved sentinel
ymph nodes were negative for metastatic disease.
Patient is disease free 7 months after the operation and contin-
es follow- up.
.2. Case 2
During August 2017, a 65year-old female was  admitted to
ur department with histological ﬁnding of EPC of the right leg.
ne month before, she underwent surgical excision of a cuta-
eous lesion of the right leg. This lesion appeared brownish,
xophytic, with ulcerated surface, more suggestive for a squamous
ell carcinoma than an ulcerated nodular basal cell carcinoma. The
istological examination revealed a poroid neoplasm extending
nto the reticular dermis with a thickness of 5 mm,  10 mitoses
er 10 high-power ﬁeld, absence of lymphovascular invasion and
ree margins with a clearing distance of 2 mm.  Fig. 2 shows the
ematoxylin-eosin stain picture of the lesion.
She had a past medical history of hysterectomy and bilat-
ral salpingo-oophorectomy for uterine ﬁbromatosis, kidney
ransplantation for severe chronic renal failure, high blood pres-
ure, aneurysmal dilatation of the right common carotid artery,
ypercholesterolemia, hyperparathyroidism and previous inferior
yocardial infarction. Laboratory tests, including blood count, bio-
hemical investigations and serum viral markers were normal. prominent nucleoli (hematoxylin & eosin stain).
After multidisciplinary discussion and based on the sub-optimal
clearing margin we performed a re-excision of the previous wound
to ensure wider safety margins of at least 20 mm.  It was also decided
to perform a SLNB; the pre-operative lymph node scintigraphy
showed the presence of two  sentinel lymph nodes in the right
inguinal site. The patient underwent enlargement of the surgical
excision until 20 mm of free margin from the previous excision
and SLNB of the two  lymph nodes identiﬁed preoperatively. Recov-
ery from surgery was  uneventful and the patient was discharged
from hospital on the ﬁrst post-operative day. Histopathological
examination found no signs of residual or satellite neoplasia in the
surgical sample and the two  retrieved sentinel lymph nodes were
negative for metastatic disease. Patient is disease free 7 months
after the operation and continues follow- up.
3. Discussion
EPC is a rare neoplasm arising from the intra-epidermal ductal
portion of the eccrine sweat gland and represents approximately
0.005% of all cases of malignant epithelial neoplasms [6–8,12].
Elderly patients are the most affected, with a peak incidence
between the 6th and7th decade of life. Although it does not seem
to have a predilection for sex or race, some studies indicate a slight
prevalence in women [7,9]. The exact etiology of EPC is unclear.
Some authors suggested a possible association with radiation expo-
sure and immunosuppression although an excessive sun exposure
does not seem to be a signiﬁcant risk factor [4]. EPC may  arise
de novo or can develop from a pre-existing benign lesion; some
clinical signs, such as spontaneous bleeding, sudden growth and
ulceration in a longstanding stable lesion must lead to the suspi-
cion of malignant degeneration [10]. Clinically EPC can be presented
as an erythematous or violaceous nodule, papule or plaque with
an inﬁltrative or erosive pattern. EPC usually arises on the lower
extremities (44%), followed by the trunk (24%), head & neck (23%),
upper extremities (11%), and rarely involves other areas [3,5,11].
Microscopically, EPC is characterized by a cluster of anaplastic
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[Fig. 2. Eccrine porocarcinoma composed of basaloid cells w
ells with nuclear hyperchromasia and important mitotic activity,
xtending from the epidermis to the dermis, surrounded by ductal
umen. Robinson et al. [3] reported speciﬁc histopathologic features
f EPC which may  be predictive of a less favorable outcome. Thick-
ess is the main prognostic factors for EPC. Tumors greater than
 mm in thickness, an inﬁltrating front of tumor cells, the presence
f lymphovascular invasion, and greater than 14 mitoses per high-
ower ﬁeld were noted to be associated with a poorer prognosis
3].
The differential diagnosis includes basal and squamous cell car-
inoma, adenocarcinoma, amelanotic melanoma, Bowen’s disease,
aget’s disease and also benign lesions like ﬁbroma and pyogenic
ranuloma. Some immunohistochemical markers as carcinoem-
ryonic antigen (CEA), EMA, and p53 protein may  play a role in
he diagnosis of EPC [13].
Therapeutic options for the treatment of EPC include elec-
rofulguration, electrocautery, surgical excision, radiation and
mputation. Surgical excision with histologically clear margins is
enerally considered the treatment of choice with cure rates as
igh as 70–80 %, although a recurrence rate of up to 20% has been
eported [10]. This elevate incidence of local recurrence may be
ue to a not optimal free margin at surgical excision. Lymph node
etastases are present at diagnosis in 20% of cases and the inci-
ence of visceral metastases is reported to be 10% [8,9]. The tumor
ends to spread tangentially in the lower third of the epidermis,
hen after inﬁltrates the dermis, subcuticular fat and lymphatic
ystem. The role of sentinel lymph node biopsy remains contro-
ersial. Nouri et al reported a series of six patients underwent to
NLB which were negative [14]. Sahn and Lang investigated the
ole of SNLB in high risk EPC, they reported no positive SLNB iden-
iﬁed among six patients but one local and one distant recurrence
n follow-up [15].
Based on the observation that EPC is tumor with an important
ymph node tropism some authors have suggested the possible role
f SLNB for all or some EPC patients, but more studies are needed
16]. We  explored SLNB approach in the two observed EPC patientscal inﬁltration into the dermis (hematoxylin & eosin stain).
with non conclusive results because in both of them retrieved sen-
tinel nodes where shown to be free from metastasis.
4. Conclusions
EPC is a rare malignancy tumor; even if it can arise de novo, it
often originates from the transformation of a poroma. The diag-
nosis of EPC should be considered in the differential diagnosis of
skin lesions; early diagnosis is important because interference at
an early stage could prevent the high rates of local recurrence
and metastasis. Based on its low incidence rates scant protocols or
guidelines are available for its diagnosis and management. In the
current two case reports, we adopted SLNB as a staging and diag-
nostic tool similarly to other malignant neoplasms of the skin with
a convergence between the non-pathological ﬁnding of the lymph
nodes and the absence of disease even with a limited follow-up.
Currently, the status of the SLNB affects the clinical stage of patients
with EPC but its prognostic or potential therapeutic role remain to
be determined with Larger studies and extended follow-up.
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